AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Financial Director)
The Competition Commission is proposing new guidelines for divestiture remedies in merger inquiries referred to by the Office of Fair Trading.
A consultation document, Application of Divestiture Remedies in Merger Inquiries: Competition Commission Guidelines, deals with situations where the Commission believes a merger has resulted, or may result, in a substantial lessening of competition (SLC) and the action it may require. In general, the Commission prefers structural remedies, such as divestiture or prohibition, to behavioural remedies because structural remedies generally require less monitoring or enforcement of compliance.
The risks
The consultation paper identifies three broad categories of risk that can impair the effectiveness of divestiture remedies:
1) Composition risks - that the scope of the divestment package may be too constrained or inappropriate to attract a suitable purchaser or to allow a purchaser to operate effectively.
2) Purchaser risks - that a suitable purchaser is not available, or that the merger parties will select a weak or inappropriate purchaser.